Abbott Laboratories ABT

NYS: ABT | ISIN: US0028241000   19:32
104,27 USD (-0,57%)
(-0,57%)   19:32

29 april 2024 · Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee · Persbericht

18 april 2024 · Bedrijfsnieuws uit Amerika · Bolero.be

Kinder Morgan voldoet aan winstramingen Kinder Morgan: (+0,39%) de pijpleiding- en terminalexploitant boekte een winst van 34 cent per aandeel voor het eerste kwartaal en keurde een verhoging van het kwartaaldividend met...

17 april 2024 · Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges · Persbericht

2 april 2024 · Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve · Persbericht

1 april 2024 · Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside · Persbericht

27 maart 2024 · Abbott Hosts Conference Call for First-Quarter Earnings · Persbericht

6 maart 2024 · Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes · Persbericht

16 februari 2024 · Abbott Declares 401st Consecutive Quarterly Dividend · Persbericht

14 februari 2024 · FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve · Persbericht

1 februari 2024 · New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again · Persbericht

31 januari 2024 · Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey · Persbericht

25 januari 2024 · Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+ · Persbericht

24 januari 2024 · Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook · Persbericht

18 januari 2024 · Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms · Persbericht

3 januari 2024 · Abbott Hosts Conference Call for Fourth-Quarter Earnings · Persbericht

18 december 2023 · Abbott to Present at J.P. Morgan Healthcare Conference · Persbericht

15 december 2023 · Abbott Increases Quarterly Dividend for 52nd Consecutive Year · Persbericht

8 november 2023 · Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes · Persbericht

2 november 2023 · Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV · Persbericht

1 november 2023 · Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology · Persbericht

Mijn selecties